Macrophage Pharma is an immuno-oncology company focussed on the discovery and development of novel therapies designed to enhance anti-tumour immune responses.
Macrophage Pharma’s technology platform is designed to deliver small molecule drugs to tumour associated macrophages in a highly selective manner to activate the body’s natural immune system to fight cancer.
MACROPHAGE PHARMA ANNOUNCES APPOINTMENT OF LEADING INTERNATIONAL SCIENTIFIC ADVISORY BOARD
2018/04/11Macrophage Pharma Limited (‘MPL’) announced today that it has appointed Dr. Michael Moore as non-executive Chairman with immediate effect.
2017/08/23M Ventures Joins Investment Syndicate and the Board of Macrophage
